Trials / Completed
CompletedNCT03898037
Effect of Lifestyle and/or Metformin Intervention on Pregnancy Outcome, A Pilot Randomized Controlled Trial
Effect of Lifestyle and/or Metformin Intervention on Pregnancy Outcome in Overweight/Obese Non-pcos Infertility Women With Insulin Resistance , A Pilot Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (actual)
- Sponsor
- Reproductive & Genetic Hospital of CITIC-Xiangya · Academic / Other
- Sex
- Female
- Age
- 18 Years – 36 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of pilot trial is to compare the efficacy of lifestyle intervention, metformin intervention, lifestyle combined with metformin intervention in improving assisted reproductive technology in non-polycystic ovary syndrome(pcos) patients with overweight/obesity and insulin resistance compared with conventional clinical education. Subjects who meet the inclusion criteria will be randomized to four groups: lifestyle intervention group, metformin intervention group, lifestyle combined with metformin intervention group, and routine clinical education group. Subjects of above three intervention group will start ovulation stimulation treatment after reach the aim or duration of intervention and routine clinical education group has no intervention. All subjects are treated with the same procedures, including a long ovarian stimulation regimen, oocyte retrieval, and fertilization, followed by a planned transfer of two day-3 embryos. The primary outcome is ongoing pregnancy rate.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | weight loss intervention | weight loss intervention under the guidance of a dietitian, including: restricted energy balanced diet, aerobic exercise, etc. |
| DRUG | metformin intervention | metformin intervention with a starting dose of 0.5g bid, and the dose will be adjusted by doctors according to the patient's insulin level and adverse events. |
Timeline
- Start date
- 2019-06-13
- Primary completion
- 2021-06-30
- Completion
- 2021-06-30
- First posted
- 2019-04-01
- Last updated
- 2022-08-22
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03898037. Inclusion in this directory is not an endorsement.